Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Extension Study of RO4917838 in Japanese Patients with Schizophrenia
jRCT2080221884Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of bitopertin in schizophrenia, sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
bitopertin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT2080221884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221884.